Stocklytics Platform
Asset logo for symbol TERN
Terns Pharmaceuticals
TERN43
$7.91arrow_drop_up0.89%$0.07
Asset logo for symbol TERN
TERN43

$7.91

arrow_drop_up0.89%

AI Deep-Learning Forecast (TERN)

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Terns Pharmaceuticals (TERN) Stocklytics Forecast

According to analysts and AI price prediction models, the stock price of Terns Pharmaceuticals, Inc. (TERN) is expected to experience significant growth in the coming years. The forecasts suggest that TERN stock has strong potential for investment and is likely to deliver positive returns. Machine learning algorithms analyze various factors such as historical data, market trends, and company fundamentals to generate accurate predictions about the stock's future performance. This advanced technology has been proven to provide reliable forecasts, making it a valuable tool for investors.
Looking specifically at the TERN stock price forecast for 2023, experts and analysts predict further upward momentum. These projections indicate that Terns Pharmaceuticals, Inc. is on track for substantial growth in the next few years. Additionally, given the positive outlook and the company's strong fundamentals, TERN stock is considered a good buy. Analysts have provided favorable ratings and price targets for Terns Pharmaceuticals, Inc., further enhancing its investment appeal. Considering these factors, investors are encouraged to consider TERN stock as a potential opportunity for their portfolios.
add Terns Pharmaceuticals to watchlist

Keep an eye on Terns Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Terns Pharmaceuticals (TERN) stock?

Analysts have set a target price of $13.75 for Terns Pharmaceuticals (TERN), based on forecasts from 26 analysts. The predicted price range extends from a high of $23 to a low of $5.5. This represents a potential increase of up to 190.77% and a decrease of -30.47% from the current price of $7.91. These forecasts are as of 2021 Mar 02.
help

What are the analyst ratings for Terns Pharmaceuticals (TERN) stock?

Currently, there are no analyst ratings available for Terns Pharmaceuticals (TERN), possibly due to insufficient coverage or recent updates.
help

What is the AI price prediction for Terns Pharmaceuticals (TERN) stock?

At present, there is no AI or machine-learning-based price prediction available for Terns Pharmaceuticals (TERN) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media